Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 4/2012

01.08.2012 | Original Article

Acute bacterial prostatitis: how to prevent and manage chronic infection?

verfasst von: Byung Il Yoon, Seol Kim, Dong-Seok Han, U-Syn Ha, Seung-Ju Lee, Hyun Woo Kim, Chang-Hee Han, Yong-Hyun Cho

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

We conducted a retrospective analysis of acute bacterial prostatitis (ABP) to evaluate the factors of progressing to chronic infection and chronic pelvic pain syndrome IIIa (CPPS IIIa) from ABP. The clinical records of 480 cases compatible with a confirmed diagnosis of ABP from five urological centers between 2001 and 2010 were reviewed. We defined chronic infection (CI) as a progression to chronic bacterial prostatitis (II), epididymo-orchitis, and showing persistent pyuria and bacteriuria after treatment of ABP in admission periods when followed up at 3 months or more. Results were analyzed according to two categories: category I, developed to CI (group A, n = 49) versus recovered without CI or CPPS IIIa (group C, n = 385); and category II, developed to CPPS IIIa (group B, n = 46) versus recovered without CI or CPPS IIIa (group C, n = 385). Of the 480 ABP patients, 10.2% (49/480) progressed to CI and 9.6% (46/480) progressed to CPPS IIIa. The frequency of CI was 11.3% (49/434) and that of CPPS IIIa was 10.7% (46/431). The factors that affected progression to CI were diabetes, prior manipulation, not doing cystostomy, and urethral catheterization (P < 0.05). The factors that affected progression to CPPS IIIa were the same as CI, but prostate volume was included in the CPPS IIIa group (P < 0.05). The identification and characterization of these factors may accelerate the development of preventive, diagnostic, and therapeutic strategies for the treatment of CI and CPPS IIIa from ABP.
Literatur
1.
Zurück zum Zitat Neal DE Jr. Textbook of prostatitis. In: Nickel JC, editor. Acute bacterial prostatitis. 1st ed. Oxford: Isis Medical Media; 1999. Neal DE Jr. Textbook of prostatitis. In: Nickel JC, editor. Acute bacterial prostatitis. 1st ed. Oxford: Isis Medical Media; 1999.
2.
Zurück zum Zitat Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008;40:76–80.PubMedCrossRef Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008;40:76–80.PubMedCrossRef
3.
Zurück zum Zitat Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 2008;8:12. Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 2008;8:12.
4.
Zurück zum Zitat Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40:576–88.PubMedCrossRef Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40:576–88.PubMedCrossRef
5.
Zurück zum Zitat Ha US, Kim ME, Kim CS, Shim BS, Han CH, Lee SD, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008;31(suppl 1):S96–101.PubMedCrossRef Ha US, Kim ME, Kim CS, Shim BS, Han CH, Lee SD, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008;31(suppl 1):S96–101.PubMedCrossRef
6.
Zurück zum Zitat Cho IR, Lee KC, Lee SE, Jeon JS, Park SS, Sung LH, et al. Clinical outcome of acute bacterial prostatitis: a multicenter study. Korean J Urol. 2005;46:1034–9. Cho IR, Lee KC, Lee SE, Jeon JS, Park SS, Sung LH, et al. Clinical outcome of acute bacterial prostatitis: a multicenter study. Korean J Urol. 2005;46:1034–9.
7.
Zurück zum Zitat Nickel JC, Berger R, Pontari M. Changing paradigms for chronic pelvic pain: a report from the chronic pelvic pain/chronic prostatitis scientific workshop, October 19–21, 2005, Baltimore, MD. Rev Urol. 2006;8:28–35.PubMed Nickel JC, Berger R, Pontari M. Changing paradigms for chronic pelvic pain: a report from the chronic pelvic pain/chronic prostatitis scientific workshop, October 19–21, 2005, Baltimore, MD. Rev Urol. 2006;8:28–35.PubMed
8.
Zurück zum Zitat Zhanel GG, Nicolle LE, Harding GK. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group. Clin Infect Dis. 1995;21:316–22.PubMedCrossRef Zhanel GG, Nicolle LE, Harding GK. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group. Clin Infect Dis. 1995;21:316–22.PubMedCrossRef
9.
Zurück zum Zitat Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31(suppl 1):S54–7.PubMedCrossRef Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31(suppl 1):S54–7.PubMedCrossRef
11.
Zurück zum Zitat Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164:76–80.PubMedCrossRef Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164:76–80.PubMedCrossRef
12.
Zurück zum Zitat Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002;167:1363–6.PubMedCrossRef Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002;167:1363–6.PubMedCrossRef
13.
Zurück zum Zitat Richardson RD, Engel CC Jr. Evaluation and management of medically unexplained physical symptoms. Neurologist. 2004;10:18–30.PubMedCrossRef Richardson RD, Engel CC Jr. Evaluation and management of medically unexplained physical symptoms. Neurologist. 2004;10:18–30.PubMedCrossRef
14.
Zurück zum Zitat Lee CB, Ha US, Yim SH, Lee HR, Sohn DW, Han CH, et al. Does finasteride have a preventive effect on chronic bacterial prostatitis? pilot study using an animal model. Urol Int. 2011;86:204–9.PubMedCrossRef Lee CB, Ha US, Yim SH, Lee HR, Sohn DW, Han CH, et al. Does finasteride have a preventive effect on chronic bacterial prostatitis? pilot study using an animal model. Urol Int. 2011;86:204–9.PubMedCrossRef
15.
Zurück zum Zitat Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35:34–9.PubMedCrossRef Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35:34–9.PubMedCrossRef
16.
17.
Zurück zum Zitat Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents 1999;11:205–211 (discussion 13-6) Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents 1999;11:205–211 (discussion 13-6)
18.
Zurück zum Zitat DE Neal Jr. Textbook of prostatitis. In: Nickel JC, editor. Treatment of acute prostatitis. 1st ed. Oxford: Isis Medical Media; 1999. DE Neal Jr. Textbook of prostatitis. In: Nickel JC, editor. Treatment of acute prostatitis. 1st ed. Oxford: Isis Medical Media; 1999.
19.
Zurück zum Zitat Millán-Rodríguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol. 2006;24:45–50.PubMedCrossRef Millán-Rodríguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol. 2006;24:45–50.PubMedCrossRef
Metadaten
Titel
Acute bacterial prostatitis: how to prevent and manage chronic infection?
verfasst von
Byung Il Yoon
Seol Kim
Dong-Seok Han
U-Syn Ha
Seung-Ju Lee
Hyun Woo Kim
Chang-Hee Han
Yong-Hyun Cho
Publikationsdatum
01.08.2012
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 4/2012
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0350-y

Weitere Artikel der Ausgabe 4/2012

Journal of Infection and Chemotherapy 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.